PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
OPIS 35 Provides “Inherently Safe” Laser Radiation for Zone 0 Hazardous Location - March 13, 2020 - Tornado Spectral Systems
In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principle investigator and undergraduate awardees for the 2020 academic year. “We are excited to support these scientists actively researching treatments... - March 12, 2020 - Cayman Chemical Company
The EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit and EDI™ Novel Coronavirus COVID-19 IgM ELISA Kits. With proven results from clinical testing in China, Epitope Diagnostics, Inc. is eager to cooperate and collaborate to combat the current COVID-19 situation. - March 06, 2020 - Epitope Diagnostics, Inc.
Sharon Yancey founded Moongate Botanicals in Austin, Texas after struggling to find products that matched her lifestyle. Moongate Botanicals skincare products are vegan, cruelty-free, and eco-friendly. These products do not contain petroleum-based ingredients, harmful chemicals, and synthetic fragrances. - March 03, 2020 - Moongate Botanicals
HSG Announces Publication of Clinical Guidelines for Physical Therapy in Huntington Disease - February 27, 2020 - Huntington Study Group
Recombinetics (RCI) today announced a collaborative research project with University of Texas Southwestern (UTSW) to identify key factors that improve the efficiency of generating interspecies chimera between pigs and humans. This near-term goal will benefit the long-term objective of advancing regenerative... - February 27, 2020 - Recombinetics, Inc.
BioStat Solutions, Inc. (BSSI), a data analytics company providing consulting services to pharmaceutical and biotechnology companies, announced today the promotion of Dr. Lin Li to Senior Director of Scientific Operations. He will have increased responsibility leading the scientific team and further... - February 10, 2020 - BioStat Solutions, Inc.
MedBiome accelerates the development of drugs targeting the gut microbiome. The RapidAIM technology enables rapid screening of the effects of compounds on live individual human microbiomes in 96 well plates. - January 30, 2020 - MedBiome
Novel Coronavirus (2019-nCoV) Real Time RT-PCR Kit is used for the qualitative detection of a novel coronavirus, identified in 2019 in Wuhan City, China, in respiratory tract specimens by real time PCR systems. - January 25, 2020 - MoBiTec GmbH
“It’s really incredible. For 15 years, Augie’s Quest has been dedicated to raising the critical funds and broad awareness needed to help fast-track ALS TDI’s cutting-edge ALS research – specifically providing ALS TDI with more than $150 million to advance its efforts to end ALS,” commented Steven Perrin Ph.D., CEO of ALS TDI. - January 24, 2020 - ALS Therapy Development Institute
ICOSEP welcomes MAGIC Africa to their network of organizations. The network is comprised of patient organizations, professional societies and volunteers, who are uniting their voices for endocrine awareness. - January 17, 2020 - ICOSEP
Leveraging its “360Start-Up” Powerhouse to Grow a Dynamic Non-Profit for Scientists - January 11, 2020 - 3Sixty Pharma Solutions
NF-kB is a protein complex that controls the transcription of DNA. It is a heterodimer sequestered in the cytoplasm. In response to activation NF-kB translocates to the nucleus to 'turn on' the expression of specific genes that keeps a cell proliferating and protects it from apoptosis. AbboMax has developed a panel of NF-kB related antibodies. - December 22, 2019 - AbboMax, Inc.
The ALS Therapy Development Institute (ALS TDI), the world’s foremost drug discovery lab focused solely on finding treatments and cures for ALS, today proudly announced that it is featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes an... - December 18, 2019 - ALS Therapy Development Institute
3Sixty Pharma Solutions LLC, www.3sixtypharma.com, last week announced the successful submission to FDA of its first Investigational New Drug (IND) Application on behalf of one of its start-up biotech clients. This news comes on the heels of the formal organization in 2018 of 3Sixty Pharma Solutions’... - December 16, 2019 - 3Sixty Pharma Solutions
On Monday it was announced that Pete Frates passed away due to complications from ALS. Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness. Though it has been five years since the Challenge, Pete’s... - December 11, 2019 - ALS Therapy Development Institute
The teenage years are an important and exciting time in our life. Our body goes through a lot of change and emotions play an important role. Body height, as well as physical appearance, become often important factors for teen self-esteem. They take influence on friendships, school, and dating success. - December 09, 2019 - Redmars America Co., Ltd.
Virun® will be amongst the 1,000+ interactive exhibitors attending the PGA Merchandise Show in Orlando, Florida January 21 through January 24. - December 06, 2019 - VIRUN
Biovalence Technologies owns a proprietary recombinant proteomic technology platform that covers around 100 different proteins with potential antiviral therapeutic. The company’s mission is to save lives by applying recent advancement in genomics and proteomics on infectious diseases that have no cure today. - December 05, 2019 - Biovalence Technologies Pte Ltd
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
American Medical Technologies (AMT), the leading independent provider of wound care solutions for long-term care and post-acute environments, has partnered with TillaCare to introduce UriCap, an innovative external urine collection device for managing female urinary incontinence (UI) in the long-term... - November 23, 2019 - American Medical Technologies
TGF-β regulates multiple biological processes, including embryonic development, adult stem cell differentiation, proliferation, homeostasis, immune regulation, wound healing, and inflammation. Multiple cells synthesize TGF-β and many cells have specific receptors for this peptide. AbboMax created a panel of TGF-β and TGF-β receptors antibodies. AbboMax, Inc. has been developing & manufacturing antibodies, FFPE cell pellets slides, for many years in California. - November 23, 2019 - AbboMax, Inc.
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. Anelixis... - November 20, 2019 - ALS Therapy Development Institute
Nuriv® releases patented CBD formulations: RELAX, SLEEP, JOINT, along with its stand-alone CBD products, Hazelnut, Chocolate Brownie and French Vanilla. These release a powerfull Micellized form of CBD in amazing flavors, such as Peanut Butter Cup and Chocolate Brownie. Micellized compounds that are water insoluble absorb quicker, half speedy onset and improved Pharmacokinetics. 20mg CBD per 10ml serving and 22 servings per 8oz. - November 20, 2019 - VIRUN
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
The School of Arts and Science of the prestigious University of Pennsylvania has tendered a public invitation for suitable individuals to participate in a waitlist randomised control trial aimed at investigating the potential benefits of the Zemedy mobile app in patients with Irritable Bowel Syndrome. - November 13, 2019 - Bold Health
Global Regenerative Group, a proven company in the field of medicine and innovation, is pleased to announce partnerships with Remodem and Aurafix. - November 09, 2019 - Global Regenerative Group
ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. - November 06, 2019 - ALPCO
NuvOx Pharma, Inc, a clinical stage biopharmaceutical company developing NanO2TM emulsion for oxygen delivery today announced the issuance of US Patent 10,456,468 – Fractionated Radiotherapy and Chemotherapy with an Oxygen Therapeutic. NanO2TM emulsion is designed to increase tumor oxygen levels... - November 03, 2019 - NuvOx Pharma
MD Stem Cells plans to continue ACIST Alzheimer’s, Autism, Dementia study at least additional year. - October 31, 2019 - MD Stem Cells
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test. The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS. - October 30, 2019 - ALPCO
MD Stem Cells reports how hereditary stroke syndrome may benefit. - October 30, 2019 - MD Stem Cells
Aciont was issued a U.S. patent that covers an important aspect of the novel design of its main Visulex ocular drug delivery system which has been tested for safety and efficacy in its lead clinical program under U.S. IND. - October 12, 2019 - Aciont Inc.
Omni Health, Inc., (OTC: OMHE) Andrey Soloviev announces his resignation from the position of CEO of Omni Health, Inc. effective 08/20/2019.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term... - September 27, 2019 - Omni Health
Thrivous, the human enhancement company, has launched Formula 3 of Clarity Daily Nootropic. Formula 3 incorporates Synapsa, a standardized and patented form of bacopa monnieri that has been the subject of more than 30 years of clinical study for memory support.
While most cognitive health supplements... - September 25, 2019 - Thrivous
The NIH’s National Institute of Arthritis and Musculoskeletal & Skin Diseases (NIAMS) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop its patented small molecule bone repair agent KMN-159. - September 25, 2019 - Cayman Chemical Company
Oncoheroes Biosciences Inc (“Oncoheroes”) and Boehringer Ingelheim International GmbH (“Boehringer Ingelheim”) have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered and developed by Boehringer... - September 19, 2019 - Oncoheroes Biosciences Inc.
Thrivous, the human enhancement company, has upgraded Alpha, the neuroprotector, to include phosphatidylserine. Alpha is a cognitive longevity enhancement supplement that Thrivous developed to support healthy brain aging. Thrivous designed formula 2 of Alpha to enhance its efficacy, enabled by improvements... - September 19, 2019 - Thrivous
Scintica Instrumentation Inc. is excited to announce its exclusive distribution agreement with Aspect Imaging for the M-Series(TM) MRI systems for scientific research. With more than 100 MRI installations worldwide, Aspect’s compact MRI systems are self-shielding, cryogen free and do not need any... - September 18, 2019 - Scintica Instrumentation
Digital DNAtix Ltd., the Israeli cyber genetics startup, has announced the first free anonymous genetic vault service. DNAtix developed the Cyber Genetics Smart Platform for Digital Genetics. Lack of privacy is currently a barrier for so many people who want to have their DNA tested but are afraid to give their genetic data away. As of today anyone can anonymously upload their raw file from 23&Me and Ancestry.com onto the DNAtix platform. - September 17, 2019 - Digital DNAtix Ltd.
On October 24, 2019 join the ALS Therapy Development Institute in Cambridge for an outdoor celebration of autumn with hard cider, apple cider donuts, seasonal snacks, music, and fun – all in support of a great cause. - September 10, 2019 - ALS Therapy Development Institute
Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®, is established for the high-level expression of homogeneously folded disulfide bond containing proteins in the cytoplasm of E. Coli. The technology offers all cost benefits of expression... - September 10, 2019 - Paras Biopharmaceuticals Finland Oy
Vascular Biosciences (VBS) is pleased to announce the receipt of a Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA) for the Endoarterial Biopsy Catheter (EABC) to take pulmonary artery biopsies in patients who have Group 1 pulmonary arterial hypertension (PAH).
“With... - September 06, 2019 - Vascular BioSciences, Inc
Pleased to announce a new distribution partnership between Global Regenerative Group, a company which has developed extensive experience in the most advanced medical device industries, and Kanfit3D. - September 05, 2019 - Global Regenerative Group
Biosynthetic Technologies (BT) today announced it has signed on with Cayman Chemical for the production and distribution of novel Estolide compounds for pharmaceutical testing applications. BT is excited to partner with Cayman Chemical to provide discovery and pre-clinical development services to the... - September 05, 2019 - Cayman Chemical Company
Better Business Bureau (BBB) of Utah has accredited Thrivous. After review, BBB determined that Thrivous meets its Standards for Trust: build trust, advertise honestly, tell the truth, be transparent, honor promises, be responsive, safeguard privacy, and embody integrity. Thrivous has committed to continue... - September 04, 2019 - Thrivous
CrystalGenomics, Inc. (KOSDAQ: 083790) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to CG-745, a clinical stage histone deacetylase (HDAC) inhibitor being developed for several hematologic malignancies and solid tumors, for the treatment of patients... - August 30, 2019 - CrystalGenomics, Inc.
Dr. David Dayton has joined the science advisor board at Thrivous, the human enhancement company. The board informs ongoing product and service development, reflecting Thrivous' commitment to guidance from consensus science in its mission to help customers access technology with the greatest potential... - August 28, 2019 - Thrivous
Thrivous, the human enhancement company, has upgraded Clarity, the daily nootropic, to include bioavailable Vitamin B Complex. Clarity is a cognitive enhancement supplement that Thrivous developed to improve focus, memory, and mood. Thrivous designed formula 2 of Clarity to support brain function and... - August 21, 2019 - Thrivous
Zifo RnD Solutions and Scilligence Corporation announce a strategic partnership that enables Zifo to provide System Integrations Solutions for Scilligence suite of integrated informatics solutions. The partnership will help clients to easily select, evaluate, and implement solutions that fit their research... - August 18, 2019 - Zifo RnD Solutions